1. DOP50 Recommencement of Inflammatory Bowel Disease medications following colectomy for Ulcerative Colitis. (27th May 2021) Authors: Ledder, O; Lujan, R; Orlanski-Meyer, E; Friss, C; Loewenberg Weisband, Y; Greenfeld, S; Kariv, R; Lederman, N; Matz, E; Focht, G; Yanai, H; Ollech, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP61 Ethnic disparities in the management of Inflammatory Bowel Disease in Israel and impact on outcomes. (30th January 2023) Authors: Boaz, E; Ledder, O; Dagan, A; Lujan, R; Koslowsky, B; Friss, C; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Yellinek, S; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP65 Development and validation of the TUMMY-UC, a patient-reported outcome in pediatric Ulcerative Colitis: A multicenter prospective study. (21st January 2022) Authors: Turner, D; Marcovitch, L; Focht, G; Carmon, N; Tersigni, C; Ledder, O; Lev Tzion, R; Frost, K; Church, P C; Baldassano, R; Otley, A; Kappelman, M; Griffiths, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP89 Final growth in paediatric Crohn's disease is impaired also in the era of biologics: a population-based analysis from the epiIIRN administrative cohort. (25th January 2019) Authors: Assa, A; Cohen, S; Asayag, N; Dan, N; Focht, G; Ledder, O; Lederman, N; Matz, E; Cahan, A; Balicer, R; Feldman, B; Brufman, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. (18th April 2020) Authors: Shamriz, O; Simon, A J; Lev, A; Megged, O; Ledder, O; Picard, E; Joseph, L; Molho-Pessach, V; Tal, Y; Millman, P; Slae, M; Somech, R; Toker, O; Berger, M Journal: Clinical and experimental immunology Issue: Volume 200:Number 3(2020) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study. (21st January 2022) Authors: Shavit, Z; Stein, R; Aloi, M; Ledder, O; Focht, G; Urlep, D; Hyams, J; Broide, E; Vais, B; Levine, J; Shouval, D; Matar, M; Assa, A; Rosh, J; Hussey, S; Markowitz, J; Yerushalmy-Feler, A; Miele, E; Shaoul, R; Russell, R K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP16 Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease: A Multi-center Study from the Porto Group of ESPGHAN. (27th May 2021) Authors: Berger, T; Miin Lee, H; Ramasamy Padmanaban, L; Wine, E; Yerushalmi, A; Hojsak, I; Bronski, J; Serban, D; Yogev, D; Ledder, O; Lionetti, P; Scarrallo, L; Gasparetto, M; Croft, N; Miele, E; Staiano, A; Meredith, J; Aloi, M; Alvisi, P; Urlep, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP18 Proactive adalimumab trough measurements increase corticosteroid-free clinical remission in paediatric patients with Crohn's disease: the paediatric Crohn's disease adalimumab-level-based optimisation treatment (PAILOT) trial. (25th January 2019) Authors: Assa, A; Matar, M; Turner, D; Broide, E; Weiss, B; Ledder, O; Guz Mark, A; Rinawi, F; Cohen, S; Topf Olivestone, C; Shaoul, R; Yerushalmi, B; Shamir, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S012 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P150 Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN. (30th January 2023) Authors: Tal-Shifman, N; Tzivinikos, C; Gasparetto, M; Serban, D E; Zifman, E; Hojsak, I; Ledder, O; Yerushalmy Feler, A; Rolandsdotter, H; Aloi, M; Bramuzzo, M; Buderus, S; Lionetti, P; Norsa, L; Norden, C; Urlep, D; Romano, C; Shaoul, R; Martinez-Vinson, C; Karoliny, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P170 Diagnostic criteria for IBD subtype classification: a multi-centre validation cohort. (25th January 2019) Authors: Sonnino, M; Matar, M; Assa, A; Lev Zion, R; Shteyer, E; Griffiths, A; Turner, D; Ledder, O Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗